Ronald Cohn, M.D., Ph.D., has served as President and CEO of The Hospital for Sick Children (SickKids) in Toronto, Canada since May 1, 2019. Dr. Cohn joined SickKids in September 2012 as the Chief of the Division of Clinical and Metabolic Genetics, Co-Director of the Centre for Genetic Medicine, and Senior Scientist at the SickKids Research Institute. He became the Inaugural Women’s Auxiliary Chair in Clinical and Metabolic Genetics in April of 2013, and joined the department of Molecular Genetics at the University of Toronto. In 2016 he was appointed to the position of Chief of Paediatrics at SickKids, and Chair of Paediatrics at the University of Toronto. Research in Dr. Cohn’s laboratory focuses the developing therapeutic avenues for neurogenetic disorders utilizing genome editing technologies such as CRISPR. Dr. Cohn received his medical degree from the University of Essen, Germany. After his postdoctoral fellowship at the Howard Hughes Medical Institute in the laboratory of Dr. Kevin Campbell, he moved to Baltimore where he was the first combined resident in pediatrics and genetics at Johns Hopkins University. He subsequently joined the faculty of the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins where he became the director of the world’s first multidisciplinary center for hypotonia, which has earned national and international recognition. Dr. Cohn was also the director of the medical genetics residency program at Johns Hopkins. Dr. Cohn has received numerous awards including the David M. Kamsler Award for outstanding compassionate and expert care of pediatric patients in 2004; First Annual Harvard-Partners Center for Genetics and Genomics Award in Medical in 2006; and the NIH Young Innovator Award in 2008.